Thomas Griesbacher

929 total citations
38 papers, 714 citations indexed

About

Thomas Griesbacher is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Thomas Griesbacher has authored 38 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Thomas Griesbacher's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Neuropeptides and Animal Physiology (12 papers) and Apelin-related biomedical research (9 papers). Thomas Griesbacher is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Neuropeptides and Animal Physiology (12 papers) and Apelin-related biomedical research (9 papers). Thomas Griesbacher collaborates with scholars based in Austria, Switzerland and Germany. Thomas Griesbacher's co-authors include Fred Lembeck, F. Lembeck, Franz J. Legat, Martin Eckhardt, Gerhard Breipohl, Jochen Knolle, Beate Tiran, H. Juan, W. Sametz and G.E. Leighton and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Pharmacology and Neuroscience Letters.

In The Last Decade

Thomas Griesbacher

37 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Griesbacher Austria 15 423 256 191 123 115 38 714
Nour‐Eddine Rhaleb United States 19 439 1.0× 408 1.6× 255 1.3× 48 0.4× 128 1.1× 39 963
Jean‐Luc Paquet France 14 153 0.4× 317 1.2× 91 0.5× 24 0.2× 77 0.7× 22 603
Lee Chao United States 11 263 0.6× 178 0.7× 82 0.4× 30 0.2× 17 0.1× 16 490
Luis A. Carbini United States 14 244 0.6× 226 0.9× 67 0.4× 20 0.2× 34 0.3× 16 595
Nathalie Bonello‐Palot France 15 117 0.3× 357 1.4× 250 1.3× 100 0.8× 83 0.7× 42 859
Satoko Kubo Japan 14 116 0.3× 154 0.6× 63 0.3× 43 0.3× 219 1.9× 18 684
Carlos D. Figueroa United Kingdom 15 353 0.8× 232 0.9× 29 0.2× 18 0.1× 44 0.4× 19 637
Yoshimi Mori Japan 11 45 0.1× 250 1.0× 82 0.4× 105 0.9× 219 1.9× 12 591
M.J. Bastié France 12 67 0.2× 215 0.8× 115 0.6× 139 1.1× 51 0.4× 25 466
Anne Aries France 13 61 0.1× 460 1.8× 35 0.2× 101 0.8× 60 0.5× 21 718

Countries citing papers authored by Thomas Griesbacher

Since Specialization
Citations

This map shows the geographic impact of Thomas Griesbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Griesbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Griesbacher more than expected).

Fields of papers citing papers by Thomas Griesbacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Griesbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Griesbacher. The network helps show where Thomas Griesbacher may publish in the future.

Co-authorship network of co-authors of Thomas Griesbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Griesbacher. A scholar is included among the top collaborators of Thomas Griesbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Griesbacher. Thomas Griesbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Griesbacher, Thomas, et al.. (2007). Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) α and γ in experimental acute pancreatitis. International Immunopharmacology. 8(2). 325–329. 13 indexed citations
4.
5.
Legat, Franz J., Thomas Griesbacher, Rudolf Schicho, et al.. (2002). Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats. Neuroscience Letters. 329(3). 309–313. 23 indexed citations
6.
Griesbacher, Thomas, et al.. (2002). Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats. British Journal of Pharmacology. 137(5). 692–700. 11 indexed citations
7.
Griesbacher, Thomas & Franz J. Legat. (2000). Effects of the non-peptide B 2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation. Inflammation Research. 49(10). 535–540. 11 indexed citations
8.
Griesbacher, Thomas, et al.. (1999). 5-Hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors. Immunopharmacology. 43(2-3). 195–201. 5 indexed citations
9.
Griesbacher, Thomas, et al.. (1998). Vespula vulgaris venom: role of kinins and release of 5-hydroxytryptamine from skin mast cells. European Journal of Pharmacology. 351(1). 95–104. 20 indexed citations
10.
Griesbacher, Thomas, et al.. (1998). The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. British Journal of Pharmacology. 124(6). 1328–1334. 25 indexed citations
11.
Griesbacher, Thomas & Franz J. Legat. (1997). Effects of FR173657, a non‐peptide B2 antagonist, on kinin‐induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. British Journal of Pharmacology. 120(5). 933–939. 24 indexed citations
12.
Griesbacher, Thomas, et al.. (1997). Effects of the non‐peptide B2 antagonist FR173657 on kinin‐induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. British Journal of Pharmacology. 121(3). 469–476. 29 indexed citations
13.
Legat, Franz J., et al.. (1996). Evidence for the presence of NK1 and NK3 receptors on cholinergic neurones in the guinea-pig ileum. Neuroscience Letters. 207(2). 125–128. 11 indexed citations
14.
Griesbacher, Thomas, Christian Kolbitsch, Beate Tiran, & Fred Lembeck. (1995). Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(5). 557–64. 8 indexed citations
15.
Griesbacher, Thomas, Roy L. Sutliff, & Fred Lembeck. (1994). Anti‐inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis. British Journal of Pharmacology. 112(4). 1004–1006. 9 indexed citations
16.
Griesbacher, Thomas. (1994). Blood pressure reflexes following activation of capsaicin‐sensitive afferent neurones in the biliopancreatic duct of rats. British Journal of Pharmacology. 111(2). 547–554. 5 indexed citations
17.
Legat, Franz J., Thomas Griesbacher, & F. Lembeck. (1992). CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(3). 17 indexed citations
18.
Griesbacher, Thomas & F. Lembeck. (1992). Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. British Journal of Pharmacology. 107(2). 356–360. 53 indexed citations
19.
Griesbacher, Thomas. (1992). Kinin-induced relaxations of the rat duodenum. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(1). 102–107. 8 indexed citations
20.
Griesbacher, Thomas, Fred Lembeck, & Alois Saria. (1989). Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation. British Journal of Pharmacology. 96(3). 531–538. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nour‐Eddine Rhaleb Breakdown of academic impact, for papers by Jean‐Luc Paquet Breakdown of academic impact, for papers by Lee Chao Breakdown of academic impact, for papers by Luis A. Carbini Breakdown of academic impact, for papers by Nathalie Bonello‐Palot Breakdown of academic impact, for papers by Satoko Kubo Breakdown of academic impact, for papers by Carlos D. Figueroa Breakdown of academic impact, for papers by Yoshimi Mori Breakdown of academic impact, for papers by M.J. Bastié Breakdown of academic impact, for papers by Anne Aries
Rankless by CCL
2026